Background Anticoagulation therapy reduces stroke risk in patients with atrial fibrillation (AF), but it is often underused ...
AnaptysBio may have ended last year on a low, but 2025 is looking up with the news that its PD-1 agonist rosnilimab has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback